Therefore, it can be suggested a dual protection during CKD mediated by 1,25D3: 1) reduction of the macrophagic fibrotic capability and 2) reductions of lipid accumulation by various mechanisms, including TGF-β-induced LB formation (Figure 3). This evidence concerns the gene TGFB1 and chronic kidney disease.